Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	205,878	114,719	77,801	93,615	82,147	50,089
Market Cap Growth	51.07%	47.45%	-16.89%	13.96%	64.00%	-43.52%
Enterprise Value	234,857	121,268	80,085	92,600	80,183	47,913
Last Close Price	1512.00	838.59	568.87	677.58	590.51	356.53
PE Ratio	62.53	29.27	20.36	23.05	23.13	16.89
Forward PE	41.34	25.79	17.15	21.23	21.38	14.68
PS Ratio	7.56	5.76	4.68	7.06	6.89	4.73
PB Ratio	6.48	3.56	3.50	4.91	5.21	3.86
P/TBV Ratio	-	-	-	8.10	10.28	9.93
P/FCF Ratio	-	32.15	-	36.39	23.50	41.78
P/OCF Ratio	-	23.61	26.67	24.75	21.89	18.47
PEG Ratio	1.38	1.61	1.91	1.46	1.14	1.17
EV/Sales Ratio	8.62	6.09	4.82	6.98	6.72	4.53
EV/EBITDA Ratio	27.58	18.30	15.23	19.18	18.82	13.38
EV/EBIT Ratio	37.65	24.53	18.99	21.81	20.69	14.89
EV/FCF Ratio	-	33.98	-	36.00	22.94	39.97
Debt / Equity Ratio	0.86	0.86	0.40	0.05	0.01	0.01
Debt / EBITDA Ratio	3.21	4.13	1.66	0.19	0.04	0.03
Debt / FCF Ratio	-	7.79	-	0.36	0.05	0.11
Asset Turnover	-	0.37	0.56	0.65	0.70	0.68
Inventory Turnover	-	2.47	2.90	2.49	2.95	2.30
Quick Ratio	-	0.70	1.22	1.99	1.78	2.11
Current Ratio	-	0.91	1.73	3.14	2.80	2.91
Return on Equity (ROE)	-	14.59%	18.12%	23.29%	24.72%	24.06%
Return on Assets (ROA)	-	5.77%	8.87%	12.92%	14.31%	12.95%
Return on Capital (ROIC)	8.51%	6.78%	10.31%	14.76%	16.70%	15.15%
Return on Capital Employed (ROCE)	-	10.90%	13.10%	20.50%	23.20%	23.20%
Earnings Yield	1.60%	3.42%	4.91%	4.34%	4.32%	5.92%
FCF Yield	-	3.11%	-7.07%	2.75%	4.26%	2.39%
Dividend Yield	0.53%	-	1.29%	0.89%	0.93%	0.80%
Payout Ratio	-	-	26.14%	20.10%	21.03%	13.14%
Buyback Yield / Dilution	0.03%	-0.03%	-0.19%	-0.02%	1.03%	0.25%
Total Shareholder Return	0.56%	-0.03%	1.10%	0.86%	1.97%	1.05%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.